Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 216

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Regulation of HOXA-10 Expression by Testosterone in Vitro and in the Endometrium of Patients with Polycystic Ovary Syndrome

Open access
Cermik, Dilek, Selam, Belgin, Taylor, Hugh S.·2003·The Journal of Clinical Endocrinology & Metabolism

Abstract

Polycystic ovary syndrome (PCOS) affects approximately 5% of reproductive-age women and is characterized by anovulation and increased androgen production. Despite the ability to correct ovulatory disorders, pregnancy rates remain paradoxically low, and spontaneous pregnancy loss rates are high. To determine whether uterine dysfunction contributed to the adverse reproductive outcomes in PCOS, we assessed the effect of the increased ovarian androgens on a well-characterized gene essential to endometrial receptivity. Up-regulation of HOXA10 in the endometrium is necessary for receptivity to embryo implantation. In vitro, HOXA10 expression was repressed by testosterone but not by dehydroepiandrosterone, dehydroepiandrosterone sulfate, or insulin. Testosterone also prevented the increased expression of HOXA10 previously reported with estradiol or progesterone. Dihydrotestosterone produced an effect similar to that of testosterone, whereas flutamide blocked the testosterone effect. Endometrial biopsies, obtained from women with PCOS, demonstrated decreased HOXA10 mRNA. Testosterone is a novel regulator of HOXA10. Diminished uterine HOXA10 expression may contribute to the diminished reproduction potential of women with PCOS.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jc.2002-021072

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 51

  1. Hull, 1987, Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies., Gynecol Endocrinol, 1, 235, 10.3109/09513598709023610 · DOI · Paper page
  2. Dunaif, 2001, Current concepts in the polycystic ovary syndrome., Annu Rev Med, 52, 401, 10.1146/annurev.med.52.1.401 · DOI · Paper page
  3. Knochenhauer, 1998, Prevalence of the polycystic ovary syndrome in unselected black and white women of the Southeastern United States: a prospective study., J Clin Endocrinol Metab, 83, 3078
  4. Asuncion, 2000, A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain., J Clin Endocrinol Metab, 85, 2434
  5. Diamanti-Kandarakis, 1999, A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile., J Clin Endocrinol Metab, 84, 4006, 10.1210/jcem.84.11.6148 · DOI · Paper page
  6. Venkatesan, 2001, Insulin resistance in polycystic ovary syndrome: progress and paradoxes., Recent Prog Horm Res, 56, 205, 10.1210/rp.56.1.295 · DOI · Paper page
  7. Dunaif, 1997, Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis., Endocr Rev, 18, 774
  8. Poretsku, 1999, The insulin-related ovarian regulatory system in health and disease., Endocr Rev, 20, 535, 10.1210/edrv.20.4.0374 · DOI · Paper page
  9. Jakubowicz, 2002, Effects of metformin on early pregnancy loss in the polycystic ovary syndrome., J Clin Endocrinol Metabol, 87, 524, 10.1210/jcem.87.2.8207 · DOI · Paper page
  10. Azziz, 1998, Adrenal androgen excess in the polycystic ovary syndrome sensitivity and responsivity of the hypothalamic-pituitary-adrenal axis., J Clin Endocrinol Metabol, 83, 2317
  11. Azziz, 1989, Reproductive endocrinologic alterations in female asymptomatic obesity., Fertil Steril, 52, 703, 10.1016/S0015-0282(16)61020-8 · DOI
  12. Homburg, 1996, Polycystic ovary syndrome—from gynecological curiosity to multisystem endocrinology., Hum Reprod, 11, 29, 10.1093/oxfordjournals.humrep.a019031 · DOI · Paper page
  13. Lobo, 2000, The importance of diagnosing the polycystic ovary syndrome., Ann Intern Med, 132, 989, 10.7326/0003-4819-132-12-200006200-00010 · DOI · Paper page
  14. Homburg, 1988, Influence of serum luteinizing hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome., Br Med J, 297, 1024, 10.1136/bmj.297.6655.1024 · DOI · Paper page
  15. Tulppala, 1993, Polycystic ovaries and levels of gonadotrophins and androgen in recurrent miscarriage: prospective study in 50 women., Br J Obstet Gynaecol, 100, 348, 10.1111/j.1471-0528.1993.tb12978.x · DOI
  16. Sagle, 1988, Recurrent early miscarriage and polycystic ovaries., Br Med J, 297, 1027, 10.1136/bmj.297.6655.1027 · DOI · Paper page
  17. Lewis, 1978, A gene complex controlling segmentation in Drosophila., Nature, 276, 565, 10.1038/276565a0 · DOI · Paper page
  18. McGinnis, 1984, A conserved DNA sequence in homeotic genes of the Drosophila Antennapedia and bithorax complexes., Nature, 308, 428, 10.1038/308428a0 · DOI · Paper page
  19. McGinnis, 1984, A homologous protein-coding sequence in Drosophila homeotic genes and its conservation in other metazoans., Cell, 37, 403, 10.1016/0092-8674(84)90370-2 · DOI · Paper page
  20. McGinnis, 1992, Homeobox genes and axial patterning., Cell, 68, 283, 10.1016/0092-8674(92)90471-N · DOI · Paper page
  21. Krumlauf, 1994, Hox genes in vertebrate development., Cell, 78, 191, 10.1016/0092-8674(94)90290-9 · DOI · Paper page
  22. Block, 2000, In utero diethylstilbestrol (DES) exposure alters Hox gene expression in the developing müllerian system., FASEB J, 14, 1101, 10.1096/fasebj.14.9.1101 · DOI · Paper page
  23. Taylor, 2000, The role of HOX genes in human implantation., Hum Reprod Update, 6, 75, 10.1093/humupd/6.1.75 · DOI
  24. Satokata, 1995, Sexually dimorphic sterility phenotypes in Hoxa10-deficient mice., Nature, 374, 460, 10.1038/374460a0 · DOI · Paper page
  25. Bagot, 2000, Alteration of maternal Hoxa10 expression by in vivo gene transfection affects implantation., Gene Ther, 7, 1378, 10.1038/sj.gt.3301245 · DOI · Paper page
  26. Taylor, 1998, HOXA10 is expressed in response to sex steroids at the time of implantation in the human endometrium., J Clin Invest, 101, 1379, 10.1172/JCI1597 · DOI · Paper page
  27. Taylor, 1999, Sex steroids mediate HOXA11 expression in the human peri-implantation endometrium., J Clin Endocrinol Metab, 84, 1129
  28. Horie, 1992, Immunohistochemical localisation of androgen receptor in human endometrium, decidua, placenta and pathological conditions of the endometrium., Hum Reprod, 7, 1461, 10.1093/oxfordjournals.humrep.a137595 · DOI
  29. Okon, 1998, Serum androgen levels in women who have recurrent miscarriages and their correlation with markers of endometrial function., Fertil Steril, 69, 682, 10.1016/S0015-0282(98)00007-7 · DOI · Paper page
  30. Wu, 2000, Ovarian-adrenal cross-talk in polycystic ovary syndrome: evidence from wedge resection., Eur J Endocrinol, 143, 383, 10.1530/eje.0.1430383 · doi:10.1530/eje.0.1430383
  31. Kowalska, 2001, Insulin, leptin, IGF-I and insulin-dependent protein concentrations after insulin-sensitizing therapy in obese women with polycystic ovary syndrome., Eur J Endocrinol, 144, 509, 10.1530/eje.0.1440509 · DOI
  32. Escobar-Morreale, 2001, Receiver operating characteristic analysis of the performance of basal serum hormone profiles for the diagnosis of polycystic ovary syndrome in epidemiological studies., Eur J Endocrinol, 145, 619, 10.1530/eje.0.1450619 · DOI · Paper page
  33. Morin-Papunen, 2000, Insulin sensitivity, insulin secretion, and metabolic and hormonal parameters in healthy women and women with polycystic ovarian syndrome., Hum Reprod, 15, 1266, 10.1093/humrep/15.6.1266 · DOI · Paper page
  34. Noyes, 1955, Dating the endometrial biopsy., Fertil Steril, 1, 3, 10.1016/S0015-0282(16)30062-0 · DOI · Paper page
  35. Holinka, 1986, Effects of steroid hormones and antisteroids on alkaline phosphatase activity in human endometrial cancer cells., Cancer Res, 46, 2771
  36. Lessey, 1996, Characterization of the functional progesterone receptor in an endometrial adenocarcinoma cell line (Ishikawa): progesterone-induced expression of the α1 integrin., J Steroid Biochem Mol Biol, 59, 31, 10.1016/S0960-0760(96)00103-3 · DOI
  37. Lovely, 2000, Characterization of androgen receptors in a well-differentiated endometrial adenocarcinoma cell line (Ishikawa)., J Steroid Biochem Mol Biol, 74, 235, 10.1016/S0960-0760(00)00127-8 · DOI
  38. Markiewicz, 1997, Estrogenic and progestagenic activities of physiologic and synthetic androgens, as measured by in vitro bioassays., Methods Find Exp Clin Pharmacol, 19, 215
  39. Tada, 1993, Aromatase activity and the effect of estradiol and testosterone on DNA synthesis in endometrial carcinoma cell lines., J Steroid Biochem Mol Biol, 44, 661, 10.1016/0960-0760(93)90276-3 · DOI
  40. Holinka, 1992, Growth-promoting effects of progesterone in a human endometrial cancer cell line (Ishikawa-Var I)., J Steroid Biochem Mol Biol, 43, 635, 10.1016/0960-0760(92)90288-T · DOI
  41. Littlefield, 1990, A simple and sensitive microtiter plate estrogen bioassay based on stimulation of alkaline phosphatase in Ishikawa cells: estrogenic action of Δ5 adrenal steroids., Endocrinology, 127, 2757, 10.1210/endo-127-6-2757 · DOI · Paper page
  42. Nestler, 1998, Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome., N Engl J Med, 338, 1876, 10.1056/NEJM199806253382603 · DOI · Paper page
  43. Utiger, 1996, Insulin and the polycystic ovary syndrome., N Engl J Med, 335, 657, 10.1056/NEJM199608293350909 · DOI
  44. Garcia, 1977, The use of clomiphene citrate., Fertil Steril, 28, 707, 10.1016/S0015-0282(16)42670-1 · DOI · Paper page
  45. Cook, 1984, Induction of luteal phase defect with comiphene citrate., Am J Obstet Gynecol, 149, 613, 10.1016/0002-9378(84)90244-8 · DOI
  46. Balasch, 1983, Luteal phase evaluation after clomiphene-chorionic gonadotrophin-induced ovulation., Int J Fertil, 28, 104
  47. Gerli, 2000, Use of ethinyl estradiol to reverse the antiestrogenic effects of clomiphene citrate in patients undergoing intrauterine insemination: a comparative, randomized study., Fertil Steril, 73, 85, 10.1016/S0015-0282(99)00447-1 · DOI
  48. Li, 1992, A prospective, randomized, cross-over study comparing the effects of clomiphene citrate and clyclofenil on endometrial morphology in the luteal phase of normal, fertile women., Br J Obstet Gynaecol, 1999, 1008, 10.1111/j.1471-0528.1992.tb13708.x · DOI
  49. Thatcher, 1988, The effects of clomiphene citrate on the histology of human endometrium in regularly cycling women undergoing in vitro fertilization., Fertil Steril, 49, 296, 10.1016/S0015-0282(16)59719-2 · DOI
  50. Hecht, 1990, Luteal insufficiency: correlation between endometrial dating and integrated progesterone output in clomiphene citrate-induced cycles., Am J Obstet Gynecol, 163, 1986, 10.1016/0002-9378(90)90785-6 · doi:10.1016/0002-9378(90)90785-6
  51. Fritz, 1991, Effect of clomiphene citrate treatment on endometrial estrogen and progesterone receptor induction in women., Am J Obstet Gynecol, 165, 177, 10.1016/0002-9378(91)90247-O · DOI

Cited by

See all 216

Metadata

Authors
Cermik, D., Selam, B., & Taylor, H. S.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2003-01-01
Volume
88
Issue
1
Pages
238-243
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2078214818
Cited by
216
References
7
FWCI
6.28
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Regulation of HOXA-10 Expression by Testosterone in Vitro and in the Endometrium of Patients with Polycystic Ovary Syndrome. https://app.cochat.ai/papers/10.1210/jc.2002-021072
The paper
Cermik, D., Selam, B., & Taylor, H. S. (2003). Regulation of HOXA-10 Expression by Testosterone in Vitro and in the Endometrium of Patients with Polycystic Ovary Syndrome. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2002-021072

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.